NASA Sets Launch Date for Mission to $10 Quintillion Asteroid

After disappointing setbacks and delays, NASA has finally got its mission to an invaluable asteroid made of precious metals back on track.

Rock of Riches

After disappointing setbacks and a delay over the summer, NASA says it's finally reviving its mission to explore a tantalizing and giant space rock lurking deep in the Asteroid Belt.

Known as 16 Psyche, the NASA-targeted asteroid comprises a full one percent of the mass of the Asteroid Bet, and is speculated to be the core of an ancient planet. But Psyche's size isn't what intrigues scientists so much as its metal-rich composition, believed to be harboring a wealth of iron, nickel, and gold worth an estimated $10 quintillion — easily exceeding the worth of the Earth's entire economy. Although, to be clear, they're not interested in the metals' monetary value but rather its possibly planetary origins.

Back On Track

Initially slated to launch in August 2022, NASA's aptly named Psyche spacecraft became plagued with a persistent flight software issue that led the space agency to miss its launch window that closed on October 11.

But after surviving an independent review determining whether the mission should be scrapped or not, NASA has formally announced that its spacecraft's journey to Psyche will be going ahead, planned to launch aboard a SpaceX Falcon Heavy rocket as early as October 10, 2023.

"I'm extremely proud of the Psyche team," said Laurie Leshin, director of NASA's Jet Propulsion Laboratory, in a statement. "During this review, they have demonstrated significant progress already made toward the future launch date. I am confident in the plan moving forward and excited by the unique and important science this mission will return."

Although the new launch date is only a little over a year late, the expected arrival at the asteroid Psyche is set back by over three years — 2029 instead of 2026 — due to having to wait for another opportunity to slingshot off of Mars' gravity.

Peering Into a Planet

Once it arrives, the NASA spacecraft will orbit around the asteroid and probe it with an array of instruments, including a multispectral imager, gamma ray and neutron spectrometers, and a magnetometer, according to the agency.

In doing so, scientists hope to determine if the asteroid is indeed the core of a nascent planet known as a planetesimal. If it is, it could prove to be an invaluable opportunity to understand the interior of terrestrial planets like our own.

More on NASA: NASA Announces Plan to Fix Moon Rocket, and Maybe Launch It Eventually

The post NASA Sets Launch Date for Mission to $10 Quintillion Asteroid appeared first on Futurism.

The rest is here:

NASA Sets Launch Date for Mission to $10 Quintillion Asteroid

Elon Musk Meeting With Advertisers, Begging Them Not to Leave Twitter

Advertisers are fleeing Twitter in droves now that Tesla CEO Elon Musk has taken over control. Now, he's trying to pick up the pieces and begging them to return.

Advertisers are fleeing Twitter in droves now that Tesla and SpaceX CEO Elon Musk has taken over control.

Ever since officially closing the $44 billion deal, Musk has been busy gutting the company's executive suite and dissolving its board. Senior executives, as well as Twitter's advertising chief Sarah Personette, have departed as well.

After all, Musk has been very clear about his disdain for advertising for years now.

The resulting uncertainty has advertisers spooked — major advertising holding company IPG has already advised clients to pull out temporarily — and the billionaire CEO is in serious damage mode.

Now, Reuters reports, Musk is spending most of this week meeting with advertisers in New York, trying to reassure them that Twitter won't turn into a "free-for-all hellscape."

According to one of Reuters' sources, the meetings have been "very productive" — but plenty of other marketers are far from satisfied.

Advertisers are reportedly grilling Musk over his plans to address the rampant misinformation being spread on the platform, a trend that Musk himself has been actively contributing to since the acquisition.

And if he's succeeding in ameliorating advertisers in private, he's antagonizing them publicly. On Wednesday, Musk posted a poll asking users whether advertisers should support either "freedom of speech," or "political 'correctness'" — a type of false dichotomy that echoes the rhetoric of far-right conspiracy theorists and conservative pundits.

"Those type of provocations are not helping to calm the waters," an unnamed media buyer told Reuters.

Some are going public with the same sentiment.

"Unless Elon hires new leaders committed to keeping this 'free' platform safe from hate speech, it's not a platform brands can/should advertise on," Allie Wassum, global media director for the Nike-owned shoe brand Jordan, wrote in a LinkedIn post.

So far, Musk's plans for the social media platform remain strikingly muddy. In addition to the behind-the-scenes advertising plays, he's also announced that users will have to pay to retain their verification badge, though he's engaged in a comically public negotiation as to what the cost might be.

He's also hinted that previously banned users — former US president Donald Trump chief among them — might eventually get a chance to return, but only once "we have a clear process for doing so, which will take at least a few more weeks."

The move was seen by many as a way to wait out the impending midterm elections. After all, Twitter has played a huge role in disseminating misinformation and swaying elections in the past.

While advertisers are running for the hills, to Musk advertising is clearly only a small part of the picture — even though historically, social giants like Twitter have struggled to diversify their revenue sources much beyond display ads.

Musk nodded to that reality in a vague open letter posted last week.

"Low relevancy ads are spam, but highly relevant ads are actually content!" he wrote in the note, addressed to "Twitter advertisers."

Big picture, Twitter's operations are in free fall right now and Musk has yet to provide advertisers with a cohesive plan to pick up the pieces.

While he's hinted at the creation of a new content moderation council made up of both "people from all viewpoints" and "wildly divergent views," advertisers are clearly going to be thinking twice about continuing their business with Twitter.

With or without advertising, Twitter's finances are reportedly in a very deep hole. The billions of dollars Musk had to borrow to finance his mega acquisition will cost Twitter around $1 billion a year in interest alone.

The company also wasn't anywhere near profitable before Musk took over, losing hundreds of millions of dollars in a single quarter.

Whether that picture will change any time soon is as unclear as ever, especially in the face of a wintry economy.

But, of course, Musk has proved his critics wrong before. So anything's possible.

READ MORE: Advertisers begin to grill Elon Musk over Twitter 'free-for-all' [Reuters]

More on the saga: Elon Musk Pulling Engineers From Tesla Autopilot to Work on Twitter

The post Elon Musk Meeting With Advertisers, Begging Them Not to Leave Twitter appeared first on Futurism.

The rest is here:

Elon Musk Meeting With Advertisers, Begging Them Not to Leave Twitter

China Plans to Send Monkeys to Space Station to Have Sex With Each Other

Chinese astronauts are reportedly planning to let monkeys loose on their brand-new space station to have them have sex with each other.

Chinese scientists are reportedly planning to send monkeys to its new Tiangong space station for experiments that will involve the animals mating and potentially reproducing, the South China Morning Post reports.

It's a fascinating and potentially controversial experiment that could have major implications for our efforts to colonize space: can mammals, let alone humans, successfully reproduce beyond the Earth?

According to the report, the experiment would take place in the station's largest capsule, called Wentian, inside two biological test cabinets that can be expanded.

After examining the behavior of smaller creatures, "some studies involving mice and macaques will be carried out to see how they grow or even reproduce in space," Zhang Lu, a researcher at the Chinese Academy of Sciences in Beijing, said during a speech posted to social media earlier this week, as quoted by the SCMP.

"These experiments will help improve our understanding of an organism’s adaptation to microgravity and other space environments," he added.

Some simpler organisms, including nematodes and Japanese rice fish, have been observed reproducing in space.

But more complex life forms have struggled. In 2014, a Russian experiment to see whether geckos could produce offspring in space failed when all the critters died.

And the failure rate for mammals, so far, has been total. Soviet Union scientists got mice to mate during a space flight in 1979, but none of them gave birth after being returned to Earth.

In other words, getting monkeys to reproduce on board a space station will be anything but easy. For one, just dealing with living creatures in space can pose immense challenges. The astronauts will "need to feed them and deal with the waste," Kehkooi Kee, a professor with the school of medicine at Tsinghua University, told the SCMP.

Then there's the fact that astronauts will have to keep the macaques happy and comfortable, something that experts say will be challenging since long term confinement in the spartan environments of space habitats could cause immense stress for the simians.

And even if astronauts successfully set the mood for the monkeys, the physics of sex in space are predicted to be challenging.

"Firstly, just staying in close contact with each other under zero gravity is hard," Adam Watkins, an associate professor of reproductive physiology at University of Nottingham, wrote in a 2020 open letter highlighted by the SCMP. "Secondly, as astronauts experience lower blood pressure while in space, maintaining erections and arousal are more problematic than here on Earth."

With its new space station in nearly full operation, China isn't shying away from asking some big questions — but whether these experiments will play out as expected is anything but certain.

READ MORE: Chinese scientists plan monkey reproduction experiment in space station [South China Morning Post]

More on sex in space: Scientists Say We Really Have to Talk About Boning in Space

The post China Plans to Send Monkeys to Space Station to Have Sex With Each Other appeared first on Futurism.

See the original post here:

China Plans to Send Monkeys to Space Station to Have Sex With Each Other

Scientists Use Actual Lunar Soil Sample to Create Rocket Fuel

A team of Chinese researchers claim to have turned lunar regolith samples brought back by the country's Chang'e 5 mission into a source of fuel.

Fill 'Er Up

A team of Chinese researchers say they managed to convert actual lunar regolith samples into a source of rocket fuel and oxygen — a potential gamechanger for future space explorers hoping to make use of in-situ resources to fuel up for their return journey.

The researchers found that the lunar soil samples can act as a catalyst to convert carbon dioxide and water from astronauts' bodies and environment into methane and oxygen, as detailed in a paper published in the National Science Review.

"In situ resource utilization of lunar soil to achieve extraterrestrial fuel and oxygen production is vital for the human to carry out Moon exploitation missions," lead author Yujie Xiong said in a new statement about the work. "Considering that there are limited human resources at extraterrestrial sites, we proposed to employ the robotic system to perform the whole electrocatalytic CO2 conversion system setup."

That means we could have a much better shot at carrying out longer duration explorations of the lunar surface in the near future.

Set It, Forget It

According to the paper, which builds on previous research suggesting lunar soil can generate oxygen and fuel, this process can be completed using uncrewed systems, even in the absence of astronauts.

In an experiment, the team used samples from China's Chang'e-5 mission, which landed in Inner Mongolia back in December 2020 — the first lunar soil returned to Earth since 1976.

The Moon soil effectively acted as a catalyst, enabling the electrocatalytic conversion of carbon dioxide into methane and oxygen.

"No significant difference can be observed between the manned and unmanned systems, which further suggests the high possibility of imitating our proposed system in extraterrestrial sites and proves the feasibility of further optimizing catalyst recipes on the Moon," the researchers conclude in their paper.

Liquified

But there's one big hurdle to still overcome: liquifying carbon dioxide is anything but easy given the Moon's frosty atmosphere, as condensing the gas requires a significant amount of heat, as New Scientist reported earlier this year.

Still, it's a tantalizing prospect: an autonomous machine chugging away, pumping out oxygen and fuel for future visitors. But for now, it's not much more than a proof of concept.

READ MORE: Scientists investigate using lunar soils to sustainably supply oxygen and fuels on the moon [Science China Press]

More on lunar soil: Bad News! The Plants Grown in Moon Soil Turned Out Wretched

The post Scientists Use Actual Lunar Soil Sample to Create Rocket Fuel appeared first on Futurism.

More here:

Scientists Use Actual Lunar Soil Sample to Create Rocket Fuel

Scientists Found a Way to Control How High Mice Got on Cocaine

A team of neuroscientists at the University of Wisconsin claim to have found a way to control how high mice can get on cocaine.

A team of neuroscientists at the University of Wisconsin claim to have found a way to control how high mice can get on a given amount of cocaine.

And don't worry — while that may sound like a particularly frivolous plot concocted by a team of evil scientists, the goal of the research is well-meaning.

The team, led by University of Wisconsin neuroscientist Santiago Cuesta, was investigating how the gut microbiome can influence how mice and humans react to ingesting the drug.

The research, detailed in a new paper published this week in the journal Cell Host & Microbe, sheds light on a vicious feedback loop that could explain cases of substance abuse disorders — and possibly lay the groundwork for future therapeutic treatments.

In a number of experiments on mice, the researchers found that cocaine was linked to the growth of common gut bacteria, which feed on glycine, a chemical that facilitates basic brain functions.

The lower the levels of glycine in the brain, the more the mice reacted to the cocaine, exhibiting abnormal behaviors.

To test the theory, the scientists injected the mice with a genetically modified amino acid which cannot break down glycine. As a result, the behavior of mice returned to normal levels.

In other words, the amino acid could curb cocaine addiction-like behaviors — at least in animal models.

"The gut bacteria are consuming all of the glycine and the levels are decreasing systemically and in the brain," said Vanessa Sperandio, senior author, and microbiologist from the University of Wisconsin, in a statement. "It seems changing glycine overall is impacting the glutamatergic synapses that make the animals more prone to develop addiction."

It's an unorthodox approach to treating addiction, but could be intriguing — if it works in people, that is.

"Usually, for neuroscience behaviors, people are not thinking about controlling the microbiota, and microbiota studies usually don't measure behaviors, but here we show they’re connected," Cuesta added. "Our microbiome can actually modulate psychiatric or brain-related behaviors."

In short, their research could lead to new ways of treating various psychiatric disorders such as substance use by adjusting the gut microbiome and not making changes to the brain chemistry.

"I think the bridging of these communities is what's going to move the field forward, advancing beyond correlations towards causations for the different types of psychiatric disorders," Sperandio argued.

READ MORE: How gut bacteria influence the effects of cocaine in mice [Cell Press]

More on addiction: Study: Magic Mushrooms Helped 83% of People Cut Excessive Drinking

The post Scientists Found a Way to Control How High Mice Got on Cocaine appeared first on Futurism.

See the original post:

Scientists Found a Way to Control How High Mice Got on Cocaine

Cats May Be Tampering With Crime Scenes, Scientists Say

Cats, ever the mischievous and frisky pets, may be harboring a lot more human DNA than once thought, possibly tampering crime scenes, a new study says.

Cat Burglar

Cats are known for not really minding their own business, getting their furry paws on just about anything they can.

And it turns out, this makes them effective vectors for DNA evidence, according to a study published last month in the journal Forensic Science International: Genetic Supplement Series.

Researchers collaborating with the Victoria Police Forensic Services Department in Australia found detectable human DNA in 80 percent of the samples collected from 20 pet cats, with 70 percent of the samples strong enough that they could be linked to a person of interest in a crime scene investigation.

"Collection of human DNA needs to become very important in crime scene investigations, but there is a lack of data on companion animals such as cats and dogs in their relationship to human DNA transfer," said study lead author Heidi Monkman, a forensic scientist at Flinders University, in a statement.

"These companion animals can be highly relevant in assessing the presence and activities of the inhabitants of the household, or any recent visitors to the scene."

Here Kitty

One possible takeaway is that cats — and other companion pets like dogs — could be harboring DNA that could help solve a case.

The bigger issue, though, is that pets could introduce foreign DNA that muddles a crime scene, possibly leading to an innocent person being implicated. A pet could be carrying the DNA of a complete stranger, or it might bring the DNA of its owner into a crime scene that they had nothing to do with.

Monkman's colleague and co-author of the paper, Maria Goray, is an experienced crime scene investigator and an expert in DNA transfer. She believes their findings could help clear up how pets might tamper a crime scene by carrying outside DNA.

"Are these DNA findings a result of a criminal activity or could they have been transferred and deposited at the scene via a pet?" Goray asked.

It's a question worth asking — especially because innocent people have been jailed off botched DNA science far too often.

More on DNA evidence: Cops Upload Image of Suspect Generated From DNA, Then Delete After Mass Criticism

The post Cats May Be Tampering With Crime Scenes, Scientists Say appeared first on Futurism.

More here:

Cats May Be Tampering With Crime Scenes, Scientists Say

This Deepfake AI Singing Dolly Parton’s "Jolene" Is Worryingly Good

Holly Herndon uses her AI twin Holly+ to sing a cover of Dolly Parton's

AI-lands in the Stream

Sorry, but not even Dolly Parton is sacred amid the encroachment of AI into art.

Holly Herndon, an avant garde pop musician, has released a cover of Dolly Parton's beloved and frequently covered hit single, "Jolene." Except it's not really Herndon singing, but her digital deepfake twin known as Holly+.

The music video features a 3D avatar of Holly+ frolicking in what looks like a decaying digital world.

And honestly, it's not bad — dare we say, almost kind of good? Herndon's rendition croons with a big, round sound, soaked in reverb and backed by a bouncy, acoustic riff and a chorus of plaintive wailing. And she has a nice voice. Or, well, Holly+ does. Maybe predictably indie-folk, but it's certainly an effective demonstration of AI with a hint of creative flair, or at least effective curation.

Checking the Boxes

But the performance is also a little unsettling. For one, the giant inhales between verses are too long to be real and are almost cajolingly dramatic. The vocals themselves are strangely even and, despite the somber tone affected by the AI, lack Parton's iconic vulnerability.

Overall, it feels like the AI is simply checking the boxes of what makes a good, swooning cover after listening to Jeff Buckley's "Hallelujah" a million times — which, to be fair, is a pretty good starting point.

Still, it'd be remiss to downplay what Herndon has managed to pull off here, and the criticisms mostly reflect the AI's limited capabilities more than her chops as a musician. The AI's seams are likely intentional, if her previous work is anything to go off of.

Either way, if you didn't know you were listening to an AI from the get-go, you'd probably be fooled. And that alone is striking.

The Digital Self

Despite AI's usually ominous implications for art, Herndon views her experiment as a "way for artists to take control of their digital selves," according to a statement on her website.

"Vocal deepfakes are here to stay," Herndon was quoted saying. "A balance needs to be found between protecting artists, and encouraging people to experiment with a new and exciting technology."

Whether Herndon's views are fatalistic or prudently pragmatic remains to be seen. But even if her intentions are meant to be good for artists, it's still worrying that an AI could pull off such a convincing performance.

More on AI music: AI That Generates Music from Prompts Should Probably Scare Musicians

The post This Deepfake AI Singing Dolly Parton's "Jolene" Is Worryingly Good appeared first on Futurism.

Continue reading here:

This Deepfake AI Singing Dolly Parton's "Jolene" Is Worryingly Good

Huge Drone Swarm to Form Giant Advertisement Over NYC Skyline

Someone apparently thought it was a great idea to fly 500 drones over NYC as part of an ad experiment without much warning.

Droning On

Someone thinks it's a great idea to fly 500 drones over New York City to create a huge ad in the sky on Thursday evening. Because New Yorkers certainly don't have any historical reason to mistrust unknown aircraft over their skyline, right?

As Gothamist reports, the drone swarm is part of a "surreal takeover of New York City’s skyline" on behalf of — we shit you not — the mobile game Candy Crush.

Fernanda Romano, Candy Crush's chief marketing officer, told Gothamist that the stunt will "turn the sky into the largest screen on the planet" using the small, light-up drones.

Though this is not the first time the Manhattan skyline has been used as ad space — that distinction goes to the National Basketball Association and State Farm, which did a similar stunt this summer during the NBA draft — local lawmakers are ticked off about it nonetheless.

"I think it’s outrageous to be spoiling our city’s skyline for private profit," Brad Hoylman, a state senator that represents Manhattan's West Side in the NY Legislature, told the local news site. "It’s offensive to New Yorkers, to our local laws, to public safety, and to wildlife."

Freak Out

Indeed, as the NYC Audubon Society noted in a tweet, the Candy Crush crapshoot "could disrupt the flight patterns of thousands of birds flying through NYC, leading to collisions with buildings" as they migrate.

Beyond the harm this will do to birds and the annoyance it will undoubtedly cause the famously-grumpy people of New York, this stunt is also going down with very little warning, considering that Gothamist is one of the only news outlets even reporting on it ahead of time.

While most viewers will hopefully be able to figure out what's going on pretty quickly, the concept of seeing unknown aircraft above the skyline is a little too reminiscent of 9/11 for comfort — and if Candy Crush took that into consideration, they haven't let on.

So here's hoping this event shocks and awes Thursday night city-goers in a good way, and not in the way that makes them panic.

More drone warfare: Russia Accused of Pelting Ukraine Capital With "Kamikaze" Drones

The post Huge Drone Swarm to Form Giant Advertisement Over NYC Skyline appeared first on Futurism.

The rest is here:

Huge Drone Swarm to Form Giant Advertisement Over NYC Skyline

That "Research" About How Smartphones Are Causing Deformed Human Bodies Is SEO Spam, You Idiots

That

You know that "research" going around saying humans are going to evolve to have hunchbacks and claws because of the way we use our smartphones? Though our posture could certainly use some work, you'll be glad to know that it's just lazy spam intended to juice search engine results.

Let's back up. Today the Daily Mail published a viral story about "how humans may look in the year 3000." Among its predictions: hunched backs, clawed hands, a second eyelid, a thicker skull and a smaller brain.

Sure, that's fascinating! The only problem? The Mail's only source is a post published a year ago by the renowned scientists at... uh... TollFreeForwarding.com, a site that sells, as its name suggests, virtual phone numbers.

If the idea that phone salespeople are purporting to be making predictions about human evolution didn't tip you off, this "research" doesn't seem very scientific at all. Instead, it more closely resembles what it actually is — a blog post written by some poor grunt, intended to get backlinks from sites like the Mail that'll juice TollFreeForwarding's position in search engine results.

To get those delicious backlinks, the top minds at TollFreeForwarding leveraged renders of a "future human" by a 3D model artist. The result of these efforts is "Mindy," a creepy-looking hunchback in black skinny jeans (which is how you can tell she's from a different era).

Grotesque model reveals what humans could look like in the year 3000 due to our reliance on technology

Full story: https://t.co/vQzyMZPNBv pic.twitter.com/vqBuYOBrcg

— Daily Mail Online (@MailOnline) November 3, 2022

"To fully realize the impact everyday tech has on us, we sourced scientific research and expert opinion on the subject," the TollFreeForwarding post reads, "before working with a 3D designer to create a future human whose body has physically changed due to consistent use of smartphones, laptops, and other tech."

Its sources, though, are dubious. Its authority on spinal development, for instance, is a "health and wellness expert" at a site that sells massage lotion. His highest academic achievement? A business degree.

We could go on and on about TollFreeForwarding's dismal sourcing — some of which looks suspiciously like even more SEO spam for entirely different clients — but you get the idea.

It's probably not surprising that the this gambit for clicks took off among dingbats on Twitter. What is somewhat disappointing is that it ended up on StudyFinds, a generally reliable blog about academic research. This time, though, for inscrutable reasons it treated this egregious SEO spam as a legitimate scientific study.

The site's readers, though, were quick to call it out, leading to a comically enormous editor's note appended to the story.

"Our content is intended to stir debate and conversation, and we always encourage our readers to discuss why or why not they agree with the findings," it reads in part. "If you heavily disagree with a report — please debunk to your delight in the comments below."

You heard them! Get debunking, people.

More conspiracy theories: If You Think Joe Rogan Is Credible, This Bizarre Clip of Him Yelling at a Scientist Will Probably Change Your Mind

The post That "Research" About How Smartphones Are Causing Deformed Human Bodies Is SEO Spam, You Idiots appeared first on Futurism.

See more here:

That "Research" About How Smartphones Are Causing Deformed Human Bodies Is SEO Spam, You Idiots

Jeff Bezos’ Housekeeper Says She Had to Climb Out the Window to Use the Bathroom

Jeff Bezos' ex- housekeeper is suing him for discrimination that led to her allegedly having to literally sneak out out of his house to use the bathroom.

Jeff Bezos' former housekeeper is suing the Amazon founder for workplace discrimination that she says forced her to literally climb out out the window of his house to use the bathroom.

In the suit, filed this week in a Washington state court, the former housekeeper claimed that she and Bezos' other household staff were not provided with legally-mandated eating or restroom breaks, and that because there was no "readily accessible bathroom" for them to use, they had to clamber out a laundry room window to get to one.

In the complaint, lawyers for the ex-housekeeper, who is described as having worked for wealthy families for nearly 20 years, wrote that household staff were initially allowed to use a small bathroom in the security room of Bezos' main house, but "this soon stopped... because it was decided that housekeepers using the bathroom was a breach of security protocol."

The suit also alleges that housekeepers in the billionaire's employ "frequently developed Urinary Tract Infections" that they believed was related to not being able to use the bathroom when they needed to at work.

"There was no breakroom for the housekeepers," the complaint adds. "Even though Plaintiff worked 10, 12, and sometimes 14 hours a day, there was no designated area for her to sit down and rest."

The housekeeper — who, like almost all of her coworkers, is Latino — was allegedly not aware that she was entitled to breaks for lunch or rest, and was only able to have a lunch break when Bezos or his family were not on the premises, the lawsuit alleges.

The Washington Post owner has denied his former housekeeper's claims of discrimination through an attorney.

"We have investigated the claims, and they lack merit," Harry Korrell, a Bezos attorney, told Insider of the suit. "[The former employee] made over six figures annually and was the lead housekeeper."

He added that the former housekeeper "was responsible for her own break and meal times, and there were several bathrooms and breakrooms available to her and other staff."

"The evidence will show that [the former housekeeper] was terminated for performance reasons," he continued. "She initially demanded over $9M, and when the company refused, she decided to file this suit."

As the suit was just filed and may well end in a settlement, it'll likely be a long time, if ever, before we find out what really happened at Bezos' house — but if we do, it'll be a fascinating peek behind the curtain at the home life of one of the world's most powerful and wealthy men.

More on billionaires: Tesla Morale Low As Workers Still Don't Have Desks, Face Increased Attendance Surveillance

The post Jeff Bezos' Housekeeper Says She Had to Climb Out the Window to Use the Bathroom appeared first on Futurism.

See the rest here:

Jeff Bezos' Housekeeper Says She Had to Climb Out the Window to Use the Bathroom

Promoting Nanoparticle Delivery at "Cellular Level" to Advance Nanomedicine – AZoNano

Spatiotemporal delivery of nanoparticles at the cellular level is desirable in nanomedicine to deliver a maximum cytotoxic drug into cancer cells via the accumulation of the nanoparticles in tumors. Nevertheless, the cancer-associated fibroblasts (CAFs) and macrophages in tumor cells reduce the efficiency of nanoparticle delivery in the spatiotemporal region.

Study:Glutathione Pulse Therapy: Promote Spatiotemporal Delivery of Reduction-Sensitive Nanoparticles at the Cellular Level and Synergize PD-1 Blockade Therapy. Image Credit:Kateryna Kon/Shutterstock.com

In an article published in the journalAdvanced Science, glutathione (GSH) pulse therapy based on a reduction-sensitive larotaxel (LTX) prodrug was developed as a nanoparticle delivery system for tumor cells. These nanoparticle delivery systems escaped the phagocytosis of macrophages and facilitated the penetration through the CAF-induced stromal barrier, as observed in an animal model with breast cancer.

Along with improving the penetration of these nanoparticle delivery systems into tumor cells, this therapy also helped in LTX accumulation in cancer cells and refurbished the immunosuppressive microenvironment to combine PD-1 blockade therapy. Moreover, the biodistribution of the designed nanoparticle delivery systems could be analyzed by quantifying theirin vivobiodistribution between different cells.

Nanoparticles of therapeutic potency have specific sizes, shapes, and surface characteristics that primarily influence the efficiency of nanoparticle delivery systems and thus control therapeutic efficacy. Nanoparticles with a diameter range between 10 and 100 nanometers are suitable for cancer therapy, as they can effectively deliver drugs.

Smaller nanoparticles (1 to 2 nanometers) can easily leak from the normal vasculature to damage normal cells and are easily filtered by kidneys (less than 10 nanometers in diameter), while the nanoparticles that are larger than 100 nanometers are likely to be cleared from circulation by phagocytes.

With the increasing importance of nanomedicine in cancer therapy, many nanoparticle delivery systems have been approved by the United States Food and Drug Administration (USFDA). Specifically, spatiotemporal nanoparticle delivery systems were applied to cancer treatment, and their therapeutic efficiency depends on the biodistribution of agents in spatial and temporal regions in tumor cells.

Macrophages in the tumor microenvironment (TME) affect the accumulation of nanoparticle delivery systems in spatiotemporal regions since most of the delivered nanoparticles are engulfed by them. Thus, phagocytosis of macrophages in the TME nullifies the therapeutic effects of nanoparticle delivery systems in tumor tissue.

Consequently, the spatiotemporal accumulation of nanoparticle delivery systems restricted at the tumor tissue level is insufficient to exhibit therapeutic efficiency and requires advancement to the cellular level, focusing on delivering a cytotoxic drug into cancer cells.

To this end, various nanoparticle delivery systems based on liposomes, polymeric nanoparticles, polymeric micelles, polymer-drug conjugate nanoparticles, and lipid-drug conjugate nanoparticles have been developed to date. While a few of these are under preclinical or clinical trials, others are on the market.

Based on previous studies, the authors hypothesized that GSH injections could positively impact the immune-suppressive and tumor-stromal microenvironment induced by CAFs and benefits the PD-1/PD-L1 checkpoint inhibitor therapy.

Thus, to test this hypothesis, three different nanoparticle delivery systems based on reduction-sensitive LTX prodrug nanoparticles with , , and disulfide bonds were designed and synthesized. Subsequently, the GSH pre-injections and injections based on therapeutic outcomes in murine triple-negative breast cancer models with a maximum accumulation of the LTX prodrug nanoparticles, termed GSH pulse therapy, were investigated.

Moreover, to observe the changes of cumulative drugs at the cellular level, a sophisticated method was established, wherein matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), flow cytometry and cell sorting (FACS), and confocal laser scanning microscopy technologies were used to quantify the amount of drug delivered in target cells.

While MALDI-MSI imaging technology could map the biodistribution of drugs within the tissue, combining this method with a confocal microscope helped observe the changes in the LTX and LTX-SS-CA prodrugs distribution among macrophages and cancer cells.

Furthermore, combining FACS with liquid chromatography with tandem mass spectrometry (LC-MS/MS) helped quantify the accumulation of drugs in both macrophages and cancer cells. Fluorescent protein-based sophisticated transfection technology ensured the segregation of every cell type by FACS. Thus, the present study is suitable to investigate the biodistribution of nanoparticle delivery systems and antibody-drug conjugates (ADCs) at the cellular level required for advanced nanomedicine.

Overall, nanoparticle delivery systems, unlike conventional therapeutics, have the advantage of easy designing and tuning to reach the target site, not only to treat cancer but many other diseases. The GSH pulse therapy developed in the present study enables the reduction-sensitive nanoparticles to deliver the drugs to spatiotemporal regions of cancer cells that could synergize PD1 blockade therapy.

Subsequently, an analytical method that helped study the distribution of nanoparticle delivery systems at the cellular level included the integration of the FACS, MADLI-MSI, and confocal microscope technologies. Moreover, the established method was not only suitable for nanoparticle delivery systems but also ADCs and other targeted biomaterials.

Dong, S.,Zhang, Y.,Guo, X.,Zhang, C.,Wang, Z.,Yu, J.,Liu, Y et al. (2022) Glutathione Pulse Therapy: Promote Spatiotemporal Delivery of Reduction-Sensitive Nanoparticles at the Cellular Level and Synergize PD-1 Blockade Therapy.Advanced Sciences.https://onlinelibrary.wiley.com/doi/10.1002/advs.202202744

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Go here to read the rest:

Promoting Nanoparticle Delivery at "Cellular Level" to Advance Nanomedicine - AZoNano

Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX System – Yahoo Finance

HAYWARD, Calif., August 04, 2022--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of expanded energy settings for use with the family of CellFX System treatments tips in dermatology.

"Pulse Biosciences is dedicated to providing dermatologists a superior solution for the treatment of benign lesions and to advancing the CellFX System and its capabilities. Clinicians in the U.S. are now able to access broader treatment settings to provide more customized energy delivery specific to individual lesions," said Darrin Uecker, President and Chief Executive Officer of Pulse Biosciences. "We are pleased with how quickly the FDA cleared these new energy settings based on the data we provided, requiring 53 of the allotted 90-day review period, to determine that the expanded settings are safe and effective for use with the CellFX System. We appreciate the ongoing collaboration with FDA as we continue to expand the clinical applications for the CellFX System."

About Pulse Biosciences

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Companys proprietary Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The CellFX System is the first commercial product to harness the distinctive advantages of NPS technology to treat a variety of applications for which an optimal solution remains unfulfilled. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model. Visit pulsebiosciences.com to learn more.

To stay informed about the CellFX System, please visit CellFX.com and sign-up for updates.

Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to Pulse Biosciences expectations concerning customer adoption and future use of the CellFX System to address a range of dermatologic conditions, statements relating to the effectiveness of the Companys NPS technology and the CellFX System to improve the quality of life for patients, and Pulse Biosciences expectations, whether stated or implied, regarding its rights offering, financing plans and other future events. These statements are not historical facts but rather are based on Pulse Biosciences current expectations, estimates, and projections regarding Pulse Biosciences business, operations and other similar or related factors. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Pulse Biosciences control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Pulse Biosciences filings with the Securities and Exchange Commission. Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005400/en/

Contacts

Investors: Pulse BiosciencesSandra Gardiner, EVP and CFO510.241.1077IR@pulsebiosciences.com

or

Gilmartin GroupPhilip Trip Taylor415.937.5406philip@gilmartinir.com

Media: Tosk CommunicationsNadine D. Tosk504.453.8344nadinepr@gmail.com orpress@pulsebiosciences.com

Read the original here:

Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX System - Yahoo Finance

Retraction for the article Apigenin-Loaded Solid Lipid Nanoparticle At | IJN – Dove Medical Press

Li P, Bukhari SNA, Khan T, et al. Int J Nanomedicine. 2020;15:91159124.

The Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised regarding the alleged duplication of H&E images in Figure 4. Specifically,

In addition, images from Figure 4 also appear to have been duplicated with similar images from Figure 7 in Arellano-Buendia et al (2014), Oxidative Medicine and Cellular Longevity (https://doi.org/10.1155/2014/961326). Specifically,

The authors did respond to our queries but were unable to provide a satisfactory explanation for the duplicated images and the Editor requested for the article to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as Retracted.

This retraction relates to this paper

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the rest here:

Retraction for the article Apigenin-Loaded Solid Lipid Nanoparticle At | IJN - Dove Medical Press

A New Spin on the Bacterial Flagellum: Its Normal Niche and Displacement – Answers In Genesis

Antoni van Leeuwenhoek observed individual living cells for the first time in history in 1674. Two years later, he noted microbes with long, thin appendages protruding from globular cells that seemed to provide locomotion, like little feet as they moved in drops of water. He gave credit to God in his writings over these new moving wonders. These appendages are now known as flagella (fig. 1), meaning little whips (from Latin).

More than 300 years later, Dr. Michael J. Behe used the flagellum and its nanomotor to introduce the concept of irreducible complexitythe idea that a structure is so complex that all its parts must initially be present in a suitably functioning manner. The bacterial flagellum is a perfect example of irreducible complexity because all its parts must be present from the start for it to function at all.

According to Darwinian theory, any component that does not offer an advantage to an organism (i.e., does not function) will be lost or discarded. How such a structure as the bacterial flagellum could have evolved in a gradual, step-by-step process as required by classical Darwinian evolution is an insurmountable problem for evolutionists. How a flagellum operates adds an additional level of complexity to the picture.

In the twenty-first century, we know that bacteria are intricately designed but can cause problems if displaced (e.g., urinary tract infections). In the last couple years, bioengineers have taken advantage of microbe motility and designed displacement to deliver drugs to diseased body organs.

Keywords: bacterial flagellum, design, displacement, drug delivery

Figure 1. E. coli flagellum. Image credit: CDC.

In 1674, Leeuwenhoek, a Christian of the Dutch Reformed faith, was intrigued by animalcules (little animals) that he saw in his water using a single-lens microscope. Ones he described as little or minute eels were spirillum (probably Spirillum volutans), a large bacterium with flagella. However, flagella werent clearly described in detail until 1836 when Christian Ehrenberg saw them on Chromatium okenii. In 1877, Louis Pasteur, a creation microbiologist, saw bacteria in animal blood during his studies of Vibrio septiquelater called Clostridium septicum. These bacteria were used in one of his proofs for germ theory. Pasteur called them vibrios (bacteria) with eyelashes (flagella) and was able to photograph stained ones in 1877, using a flagella stain developed earlier that year by Robert Koch. These were bacteria with many flagella (today called peritrichous).

Some bacteria have a single flagellum located at the end of a rod-shaped cell. To move in an opposite direction, a bacterium simply changes the direction the flagellum rotates. Other bacteria have a flagellum at both ends of the cell, using one for going in one direction and the other for going in the opposite direction. A third group of bacteria has many flagella surrounding the cell. They wrap themselves together in a helical bundle at one end of the cell and rotate in unison to move the cell in one direction. To change direction, the flagella unwrap, move to the opposite end of the cell, reform the bundle, and again rotate in a coordinated fashion. The structural complexity and finely tuned coordination of flagella attest to the work of a Master Engineer who designed and created flagella to function in a wonderfully intricate manner (Gillen 2020a).

Fast Facts for Flagella

Personally, I find flagella fascinating in bacteria and protozoa alike. Under dark-field or phase-contrast microscopy, moving bacteria or protozoa are delightful to watch. They can move fast, spin, turn, reverse directions quickly, swarm, and even do somersaults. Sometimes, you can see the actual thin flagella under phase-contrast or dark-field microscopy. They are very tiny and very fragile, and one must be very careful in handling them. Usually, bacteria have flagella (and active motility) during their early life (1648 hours). Later, cells often retract them, going into energy-conserving modes. For the genus Bacillus, their energy goes into spore formation, and for Serratia marcescens, pigment production. Once Serratia get a deep red, they dont move at all.

Flagella can also be stained and seen under bright-field microscopy, but this takes time, patience, and skill. The flagella stain (e.g., Leifson flagella stain) is one of the hardest in microbiology.

The number of flagella vary greatly from one to hundreds per cell. Vibrio cholerae have only one flagellum (monotrichous). Most strains of E. coli have only a few flagella. This bacterium produces 510 flagella that are randomly distributed across the cell surface. Serratia marcescens and some strains of Proteus have many flagella (when Serratia marcescens swarms, it can have 1001000 flagella per swarmer cell).

Figure 3. Gram positive vs. negative flagella anatomy. Image credit: CNX OpenStax, via Wikimedia Commons.

Flagella are the Creators molecular outboard motors, providing a rapid spin through water, body liquids, and other fluids. Their most interesting aspect is that they are attached to and rotated by tiny, electrical motors made of protein. Like an electrical motor, the flagellum contains a rod (drive shaft), a hook (universal joint), L and P rings (bushings/ bearings), S and M rings (rotor), and a C-ring and stud (stator). The flagellar filament (propeller) is attached to the flagellar motor via the hook. The flagellum requires over 40 different proteins and is driven by voltage difference developed across the cell membrane. This motor is one of natures best molecular machines! Some scientists have called the bacterial flagellum the most efficient machine in the universe with its self-assembly and repair, water-cooled rotary engine, proton motive-force drive system, speeds of up to 17,000 rpm, direction-reversing capability, and hard-wired signal-transduction system with short-term memory.

The sensory and motor mechanisms of the E. coli bacterium consist of several receptors that detect the concentrations of a variety of chemicals. Secondary components extract information from these sensors, which in turn is used as input to a gradient-sensing mechanism, which drives a set of constant torque proton-powered rotary motors that propel helical flagella from 30,000 to 100,000 rpm. This allows the bacterium to move approximately ten body lengths per second. Some have been clocked at up to 100 m per second, or the equivalent of 50 body lengths per second. As a comparison, bacteria move twice as fast as cheetahs! Generally, bacteria with polar flagella move faster than those with peritrichous (many) flagella.

Again, the complexity of the bacterial flagellum is direct evidence against evolution. In the 1990s, Dr. Michael Behe argued for the intelligent design of the human body. His argument is called the principle of irreducible complexity. To illustrate the complex nature of this principal, one needs to look at flagellar design in driving.

Figure 4a. Bacillus megetarium with its flagella. Image credit: Alan Gillen

The more E. coli is studied, the more complex its behavior is revealed to be. Recent observation takes the argument of microbes by design to the next level by providing insight into how E. coli drive more orderly than some people. The motion of E. coli is not random; it is directed, ordered, and reminds one of car traffic patterns (or even ant traffic patterns). Harvard researcher, Howard Berg, discovered that E. coli swim on the right side.

In human terms, driving properly to avoid accidents takes drivers education, intelligence, and practice. It is certainly not by random chance nor accidental. This recent discovery of E. coli driving on the right sidemeaning that when placed in narrow, forked tubes, they are more likely to swim up the right-hand fork due to the counterclockwise direction in which the flagella rotate. E. coli can also cooperatively move over surfaces (swimming). Bacteria cells move better on gel surfaces than solid. All this may have clinical implications.

Bacteria may have one flagellum or many in a variety of patterns. Polar flagella extend from the ends of bacteria, whereas peritrichous flagella are distributed randomly over the entire surface (peri means around, trichous means hair). Bacteria with polar flagella may have anywhere from one flagellum to a tuft of hundreds of flagella at one or both ends of the cell. A few bacteria, called spirochetes, have internalized flagella that lie beneath the cell wall and coil around the cytoplasmic membrane. Bacterial flagella neither flex nor whip like eukaryotic flagella. Instead, they rotate like propellers on a boat. If a bacterium with a single polar flagellum were held by its flagellum so that the flagellum did not move, then the body of the whole bacterium would rotate. Rotation is accomplished by a basal body and the hook that connects the flagellum to the bacterial cell. The basal body attaches the base of the flagellum to the cytoplasmic membrane and cell wall and acts as a motor to turn the flagellum. The hook transfers the rotation from the basal body to the external flagellar filament (Gillen 2020a).

Flagella rotate counterclockwise to propel bacteria forward, driven by chemotaxis, which is the movement of bacteria in response to chemicals in the environment. These chemicals can be used as energy sources, and bacteria have receptors on their surface to detect them. When such a molecule interacts with the receptor, a signal is sent to the basal body, the flagellar motor starts, and the bacterium moves toward the energy source.

Figure 4b. Bacillus species, Bacillus cereus, Leifson flagella stain. Image credit: CDC/Dr. William Clark

Bacteria with a single polar flagellum move simply back and forth. They move forward by rotating their flagellum counterclockwise, and backward by rotating their flagellum clockwise. Bacteria with multiple flagella move via the synchronized action of all the flagella. These bacteria show an overall pattern of movement consisting of a series of runs (or swims) and tumbles. During a run, all the flagella work together as a functional bundle and rotate synchronously in a counterclockwise direction to propel the bacterium toward the energy source. During tumbles, the flagellar bundles disassemble. The time spent in runs determines how fast the bacterium moves in a specific direction and depends on the concentration of the energy source. The greater the concentration of molecules of the energy source, the more interaction with the receptors, the more rotation, and the farther the bacterium moves. As the concentration decreases, there is less interaction with the receptors, flagella are engaged less, and the bacterium does not move as far. Instead, the bacterium tumbles more often. During a tumble, when flagella turn clockwise, the bacterium ceases forward motion and jiggles. Once the tumble is completed, the bacterium moves randomly away from the site of the tumble. So the more a bacterium tumbles, the greater the chance it will not move in a definite direction.

E. coli is normally an intestinal, commensal bacterium that can adapt to new environments in the body. E. coli swims faster in the urinary tract than in the gut due to less resistance and viscosity of fluids. According to Harvard biologist Howard Berg, E. coli lives a life of luxury in the lower intestines of warm-blooded animals, including humans. Once expelled, it lives a life of penury and hazard in water, sediment, and soil. E. coli is a minor constituent of the human gut. A typical stool contains as many as 1011 (100 billion) bacteria per cubic centimeter (cm3). Up to 109 (1 billion) of these are E. coli. Most of the other bacteria are strictly anaerobic, and thus unable to live in the presence of oxygen outside of the body. Cells of E. coli can live with or without oxygen, and thus survive until they find another host or another part of the body .... If fed well, however, it grows to a density like that of its siblings there, to some 109 cells per cm3: the population of India in a spoonful (Berg 2004). Once out of this normal microhabitat and niche, it can adapt to most places in the body if given the right nutrients.

Figure 5. Reagent strips for urinalysis. Image credit: Alan Gillen.

A urinary tract infection (UTI) is an infection involving any part of the urinary systemincluding urethra, bladder, ureters, and kidneyand occurs when germs (bacteria) invade the urinary tract. UTIs are the most common type of healthcare-associated infection reported to the CDC, with 68 million UTI cases diagnosed each year in the United States. According to the CDC (2022), 80 to 90% of UTIs are caused by E. coli. For the most part, E. coli lives harmlessly in the gut, but it can cause problems if it enters the urinary system.

Figure 6. E. coli nitrate broth urine stick. Image credit: Alan Gillen.

A different scenario for displacement is when Proteus mirabilis enters the bloodstream through wounds. (The most frequent cases are among the elderly with declining immune systems.) This happens with contact between a wound or sore and an infected surface. The bacteria then induce an inflammatory response that can cause sepsis and urosepsis and damage to the kidney and ureters. On rare occasions, P. mirabilis can also colonize the lungs, perhaps by infected hospital breathing equipment, causing pneumonia. In each case, the bacteria are swimming through the blood, lymph, or body fluids via flagella.

Figure 7. Giardia intestinalis. Image credit: Stefan Walkowski, via Wikimedia Commons.

The essence of this approach is using bugs (via motorized microbes) to deliver drugs. We can use bacteria or Giardias swimming ability (via flagella) to send them to internal organs and deposit drugs.

E. colis flagella are the most studied, but magnetotactic bacteria are also promising. These species of soil bacteria synthesize iron oxide nanoparticles called magnetosomes as compasses that allow them to navigate in the earths magnetic field to find optimum conditions for growth and survival. These bacteria with microscopic magnets are perfectly shaped and ideally suited to the microscopic packages we need to target deep cancers (like breast and prostate cancer) (McKie 2022). Magnetotactic bacteria also have hyperdrive-equipped flagella and are reported to swim ten times faster than E. coli because of their gear-driven, seven-engine, magnetic-guided flagellar bundles that can accelerate from 0 to 300 micrometers (m) in one second. With this capability, they could deliver medicine quickly.

Of another example of bacteria flagella delivery systems, GEN 2020 states, A biohybrid microswimmera genetically engineered bacterium studded with nanoerythrosomescan be loaded with molecular cargo, injected into the body, and sent on a delivery mission. For example, the microswimmer could propel itself through viscous environments and tissue cells to dispense drugs at a tumor site. To get where it needs to go, the microswimmer could home in on a signal of some kind. A chemical signal could allow microswimmer dispatchers to take advantage, however passively, of a bacteriums natural sensing capabilities. Alternatively, magnetic or sound signals could allow for a more active, hands-on approach. That is, microswimmer movements could be subjected to remote control. In this example, nanoerythrosomes were attached to the bacterial membrane using a biological bond. This process preserved two important red blood cell membrane proteins: one needed to attach the nanoerythrosomes, and one to prevent macrophage uptake.

One bioengineered E. coli strain served as a bioactuator (an organism that produces a motion by converting energy and signals going into the system) performing the mechanical work of propelling through the body using flagellar rotation. The swimming capabilities of the bacteria were assessed using a custom-built algorithm and videos to document their performance. These biohybrid microswimmers performed at speeds 40% faster than other non-engineered E. coli-powered microparticles-based biohybrid microswimmers. They demonstrated a reduced immune response due to the nanoscale size of the nanoerythrosomes and adjustments to the density of coverage of nanoerythrosomes on the bacterial membrane. These biohybrid swimmers could deliver drugs faster, due to their swimming speed, and encounter less immune response, due to their composition (Genetic Engineering and Biotechnology News 2020).

Giardia are protozoans with eight flagella. As Georgia Purdon (2012) previously reported, bioengineered Giardia robots could possibly be used as nanomachines to deliver drugs to places like the kidneys. If these microrobots can imitate the swimming abilities of wild Giardia, doctors could use them for drug delivery and breaking up kidney stones. The technology has promise but still needs more work to become useful in a hospital setting.

Motile microbes are fascinating. Both bacteria and protozoa with flagella show evidence of design. Some of the first electron microscope images of the flagellum, presumably from Bergs Harvard lab, spoke for themselves in this regard. Berg was probably the foremost authority on E. coli in motion, illustrating the flagellum of bacteria. His work also inspired Dr. Richard Bliss, who spoke about the intricate creation of the bacterial flagellum ten years before Michael Behe.

Flagellated bacteria and protozoa in their designed host and place (as microbiome) can benefit their host, themselves, and nature. However, due to their mobility and adaption they can travel other places in their hosthuman or animal. Displaced from their normal niche and microhabitat, they can cause great distress and disease to their host. The most notable example with bacteria is through entering the urinary system and causing UTIs and kidney infections. And Giardia, in particular, can cause significant diarrhea and in immunocompromised children could lead to death.

Some bacteria are self-propelled via flagella equipped with magnetic crystals to navigate the body. Magnetostatic bacteria live in murky water on little oxygen, and their crystals align with the magnetic field of the earth to navigate to good environments for orientation.

Flagellated bacteria preloaded with cancer drugs offer promise in medicine. Magnetosomes carry the iron crystals, and these crystals can naturally navigate to the right body organs. But it takes the flagellum to propel the bacteria loaded with drugs and magnets to cancerous organs. Motility via flagella is key in bacterial therapy, since bacteria can actively swim and penetrate deep into tumor tissue. Tumors display irregular and chaotic vasculature, leading to areas with low oxygen concentration and nutrient limitation. Such hypoxic (low oxygen) regions are a perfect niche for anaerobic (no oxygen) and microaerophilic (low oxygen) bacteria to perform selective colonization. The mechanism behind this bacterial therapy is still not well understood, but there is evidence indicating that bacteria could perform direct oncolysis (cancer cell destruction) and stimulate the immune system. The amazing designs given by the Creator give bioengineers ideas to make their own flagellated nanofactories to function in drug delivery and to help mitigate the effects of mankinds sin-caused curse.

These discoveries may expand to use other flagellated bacteria and protozoans as well as lead to the design of bio-inspired, swimming micro-robots for nanomedicine, with site-specified and controlled drug delivery that is less invasive than surgical procedures. Bioengineers are trying to think like the Master Bioengineer in bringing healing and restoration. Thinking Gods thoughts after him (Psalm 139:17) could bring both new revelation in science and help in restoration of a diseased body in a fallen world.

Michael J. Behe, Darwins Black Box: The Biochemical Challenge to Evolution, New York: Free Press, 2006.

Michael J. Behe, A Mousetrap for Darwin: Michael J. Behe Answers His Critics, Seattle, WA: Discovery Institute, 2020.

Howard C. Berg, E. coli in Motion, New York: Springer, 2004.

CDC, Urinary Tract Infection, https://www.cdc.gov/antibiotic-use/uti.html.

Alan L. Gillen, The Genesis of Germs: Disease and the Coming Plagues in a Fallen World, rev. ed., Green Forest, AR: Master Books, 2020.

Alan L. Gillen, Body by Design: Fearfully & Wonderfully Made, Green Forest, AR: Master Books, 2020.

Alan L. Gillen and Frank Sherwin, The Design of Giardia and the Genesis of Giardiasis, Answers In-Depth, July 19, 2017, https://answersingenesis.org/biology/microbiology/design-giardia-and-genesis-giardiasis/.

Scott C. Lenaghan et al., High-Speed Microscopic Imaging of Flagella Motility and Swimming in Giardia lamblia Trophozoites, Proceedings of the National Academy of Sciences 108 (34): E550558, https://doi.org/10.1073/pnas.1106904108.

Georgia Purdom, Magnificent Motors: God Invented It First, Answers Magazine, January 1, 2012, https://answersingenesis.org/biology/microbiology/magnificent-motors/.

Drug Delivery via Biohybrid Microswimmers a Flagellum Lash Closer, Genetic Engineering and Biotechnology News, April 8, 2020. https://www.genengnews.com/topics/drug-discovery/drug-delivery-via-biohybrid-microswimmers-a-flagellum-lash-closer/.

Robin McKie, Magnets Made by Soil Bacteria Offer Hope for Breast and Prostate Cancer, The Guardian, May 8, 2022, https://www.theguardian.com/science/2022/may/08/magnets-made-by-soil-bacteria-offer-hope-for-breast-and-prostate-cancer.

About the author: Dr. Alan L. Gillen is a professor of biology at Liberty University.

Excerpt from:

A New Spin on the Bacterial Flagellum: Its Normal Niche and Displacement - Answers In Genesis

National Nanotechnology Initiative (NNI) Releases Video Trailer to Highlight Documentary on NNI over the Past 20 Years ‘NNI Retrospective Video:…

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Washington, D.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- For Immediate Release Thursday, August 4, 2022

Contacts: TV Worldwide (703) 961-9250 ext. 221 [emailprotected] http://www.TVWorldwide.com Washington, D.C., August 4, 2022 - TV Worldwide, since 1999, a pioneering web-based global TV network, announced that it was releasing a video trailer highlighting a previously released documentary on NNI over the past 20 years, entitled, 'NNI Retrospective Video: Creating a National Initiative'. The video and its trailer were produced in cooperation with the National Nanotechnology Initiative (NNI), the National Science Foundation and the University of North Carolina Greensboro. The 3-minute video trailer can be viewed by clicking here. The full video documentary can be viewed by clicking here. Video Documentary Synopsis Nanotechnology is a megatrend in science and technology at the beginning of the 21 Century. The National Nanotechnology Initiative (NNI) has played a key role in advancing the field after it was announced by President Clinton in January 2000. Neil Lane was Presidential Science Advisor. Mike Roco proposed the initiative at the White House in March 1999 on behalf of the Interagency Working Group on Nanotechnology and was named the founding Chair of NSET to implement NNI beginning with Oct. 2000. NSF led the preparation of this initiative together with other agencies including NIH, DoD, DOE, NASA, and EPA. Jim Murday was named the first Director of NNCO to support NSET. The scientific and societal success of NNI has been recognized in the professional communities, National Academies, PCAST, and Congress. Nanoscale science, engineering and technology are strongly connected and collectively called Nanotechnology. This video documentary was made after the 20th NNI grantees conference at NSF. It is focused on creating and implementing NNI, through video interviews. The interviews focused on three questions: (a) Motivation and how NNI started; (b) The process and reason for the success in creating NNI; (c) Outcomes of NNI after 20 years, and how the initial vision has been realized. About the National Nanotechnology Initiative (NNI) The National Nanotechnology Initiative (NNI) is a U.S. Government research and development (R&D) initiative. Over thirty Federal departments, independent agencies, and commissions work together toward the shared vision of a future in which the ability to understand and control matter at the nanoscale leads to ongoing revolutions in technology and industry that benefit society. The NNI enhances interagency coordination of nanotechnology R&D,supports a shared infrastructure, enables leveraging of resources while avoiding duplication, and establishes shared goals, priorities, and strategies that complement agency-specific missions and activities.The NNI participating agencies work together to advance discovery and innovation across the nanotechnology R&D enterprise. The NNI portfolio encompasses efforts along the entire technology development pathway, from early-stage fundamental science through applications-driven activities. Nanoscience and nanotechnology are prevalent across the R&D landscape, with an ever-growing list of applications that includes nanomedicine, nanoelectronics, water treatment, precision agriculture, transportation, and energy generation and storage. The NNI brings together representatives from multiple agencies to leverage knowledge and resources and to collaborate with academia and the private sector, as appropriate, to promote technology transfer and facilitate commercialization. The breadth of NNI-supported infrastructure enables not only the nanotechnology community but also researchers from related disciplines.In addition to R&D efforts, the NNI is helping to build the nanotechnology workforce of the future, with focused efforts from K12 through postgraduate research training. The responsible development of nanotechnology has been an integral pillar of the NNI since its inception, and the initiative proactively considers potential implications and technology applications at the same time. Collectively, these activities ensure that the United States remains not only the place where nanoscience discoveries are made, but also where these discoveries are translated and manufactured into products to benefit society.About TV Worldwide

Founded in 1999, TV Worldwide.com, Inc. (t/a TV Worldwide, Inc., http://www.TVWorldwide.com) is a veteran-owned Internet TV solutions company that developed the first network of community-based Internet TV channels, primarily targeting niche enterprise/professional audiences ranging from the maritime industry to the cybersecurity and federal/public sectors. Known by many in the industry as "Intelligent Internet TV," Fortune 500 companies, 40 federal government agencies, and numerous associations including the National Association of Broadcasters have partnered with TV Worldwide to utilize TV Worldwide's live and on-demand state-of-the art video streaming content applications and Internet TV channels. In recognition of the company's pioneering unique achievements in new media solutions and content development, TV Worldwide has been selected by the National Academy of Television Arts and Sciences (NATAS) to webcast past Daytime Emmy Awards and the Emmy awards for Technology and Engineering. TV Worldwide Chairman and CEO Dave Gardy, has been honored by Streaming Media Magazine as one of the 25 Most Influential People in Streaming Media. Mr. Gardy also has served as the President of the International Webcasting Association (IWA) and was a member of the Vietnam Veterans Memorial Fund Corporate Council. Contacts: TV Worldwide (703) 961-9250 ext. 221 [emailprotected] http://www.TVWorldwide.com ###

See original here:

National Nanotechnology Initiative (NNI) Releases Video Trailer to Highlight Documentary on NNI over the Past 20 Years 'NNI Retrospective Video:...

Internet of Nano Things Market is Poised to Grow at a CAGR of 24.12% during the Forecast Period of 2022-2031 – Digital Journal

The Internet of Nano Things Market was valued at USD 9.90 billion in 2019 and is expected to reach USD 36.17 billion by 2025, at a CAGR of 24.12% over the forecast period 2022 2031. The internet of nano things is very much similar to the internet of technology in which the devices that are interconnected with IoNT are miniaturized.

The development of nano-machines with communication capabilities and interconnection with micro- and macro-devices will empower IoNT, which is being increasingly seen as the next major innovation in technology. These devices have dimensions ranging from 1 nm to 100 nm, and are interconnected with classical networks leading to new networking paradigms.

The increased government spending in the aerospace and defence sector is expected to drive the IoNT market for the forecast period as IoNT recently has found major applications in the fields of Nano-drones that could be used for monitoring and carrying explosives sufficient enough that penetrates the targeted subject.

The world economic forum in 2016, released the list of top 10 emerging technologies in which nano-sensors and nanotechnology were ranked first. As the integration of the nanotechnology in various industries increases, it would increase the dependence on IoT as a platform for nanodevices which would boost the IoNT market positively.

However huge capital investment required for the development of nanotechnology is a factor that could hinder the growth of the IoNT market.

Scope of the Report

The Interconnection of nanoscale devices with existing communication networks and ultimately the Internet defines a new networking paradigm called Internet of Nano-Things. This report segments the market by Device (Nano Cameras, Nano Phones, Nanosensors, Nano Processors, Nano-Memory Cards, Nano Power Systems, Nano-Antennas, Nano Transceivers), End-user (Healthcare, Logistics, Media & Entertainment, Telecom & IT, Defense & Aerospace, Manufacturing, Energy & Power, Retail), and Geography.

Download PDF Sample Report [emailprotected] https://www.sdki.us/sample-request-80865

Key Market Trends

Healthcare Industry is Expected to Hold a Significant Share

The expectations of a better quality of life coupled with the aging population and the changing lifestyles have resulted in an increase in demand for more efficient and affordable and improved healthcare.

For instance, Cambridge University nanotech researchers collaborated with a US insurer and other corporate players to explore the commercial potential of an intelligent lavatory that captures massive amount of key data in users urine which could then be used for the timely and effective delivery of the personalized medicines.

The development of nanomedicine which uses properties of a material developed on a nanoscale offering the potential to cross natural barriers and access new sites of delivery. This nanometric size allows interaction with the DNA or small proteins at different levels in the blood or within organs, tissues, and cells.

With advancements in the fields of nanotechnology has allowed in the detection of diseases in very minute amounts or in the initial stages. For instance, in April 2019, a pair of NJIT inventors Bharath Babu Nunna and Eon Soo Lee has been instrumental in developing nanotechnology enhanced biochip to detect cancers, malaria and viral diseases such as pneumonia early in their progression with a pinprick blood test.

With increased spending on healthcare by emerging and developed economies is expected to boost the investment in the fields of IoNT which would influence the market positively.

North-America is Expected to Hold the Largest Share

Various harmful diseases are proving to be a tremendous challenge for modern medicine. This, coupled with growing consumer health awareness in the region, means for more advanced technology. Nano medicine was introduced in this industry to overcome this hurdle since it offers a number of potential ways to improve medical diagnosis & therapy, even in regenerating tissues and organs.

Nanomaterials have been instrumental in improving a bodys acceptance of transplants, artificial bone materials, and other implanted medical devices. For instance, in 2016, the US Department of Health and Human Services invested USD 500 million for the development of medical devices containing nanomaterials.

Access Free Sample Report With Graphs and [emailprotected] https://www.sdki.us/sample-request-80865

Various companies have been instrumental in developing devices that drastically helps the person to improve breathing especially for asthma and allergy sufferers. For instance, Molekuiles Air purifier that was developed by Dr. Goswami, the Director of the University of South Floridas Clean Energy Research Center uses brand new nanotechnology that is far superior to the HEPA air filters.

Competitive Landscape

The internet of nano things market is highly competitive and consists of several key players like Schneider Electric, IBM, Intel and many more. However, the market remains consolidated with many players trying to occupy the share. Their ability to continually innovate their products and services by investing significantly in research and development has allowed them to gain a competitive advantage over other players.

About Us

SDKI Incgoal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

Contact Us

Lauren Brown

600 S Tyler StSuite 2100 #140AMARILLO, TX 79101Email:[emailprotected]

Read the original:

Internet of Nano Things Market is Poised to Grow at a CAGR of 24.12% during the Forecast Period of 2022-2031 - Digital Journal

Nanomedicine in Central Nervous System Injury and Repair Market Share, Regional Growth Analysis, Upcoming Trends, Growth Factors and Leading…

A reliable Nanomedicine in Central Nervous System Injury and Repair Market report has been organized with the contributions from a group of specialists in view of definite market examination. This market report has bits of knowledge about market definition, orders, applications, and commitment. The business report additionally incorporates notable information, present market patterns, climate, mechanical advancement, impending advances, and the specialized advancement in the connected business. By considering heap of targets of the showcasing research, this report has been produced. A worldwide statistical surveying report displays significant item improvements and tracks late acquisitions, consolidations, and exploration in the business by the top market players.

At the point when a boundless market overview report is there in the image, organizations can accomplish definite market experiences with which acquiring commercial center plainly into the center turns out to be simple. This business report covers central participants methodologies that basically comprise of new item dispatches, extensions, arrangements, joint endeavors, organizations, acquisitions, and others that advance their impressions in the business. It additionally illuminates about the moving development and business approaches. With the top notch report, organizations can find out about how the market will act in the conjecture a long time with justifiable insights regarding market definition, orders, applications, and commitment.

The nanomedicine in central nervous system injury and repair market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 51,419.82 million by 2028 and grow at a CAGR of 9.91% in the above-mentioned forecast period. Increase in the prevalence of central nervous system diseases such as Parkinsons disease, senile dementia, Alzheimer disease, ocular diseases among others drives the nanomedicine in central nervous system injury and repair market.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Major Players:-

The major players covered in the nanomedicine in central nervous system injury and repair market report are Abbott, Ablynx N.V, California Life Sciences Association, CELGENE CORPORATION, Teva Pharmaceutical Industries Limited, GENERAL ELECTRIC COMPANY, Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc), Pfizer Inc, Nanosphere Inc, Johnson & Johnson Private Limited and BD among other domestic and global players.

Competitive Landscape and Nanomedicine in Central Nervous System Injury and Repair Market Share Analysis

The nanomedicine in central nervous system injury and repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to nanomedicine in central nervous system injury and repair market.

Nanomedicine is defined as the nanotechnology which is used for treating, diagnosing, preventing diseases and traumatic injury, and to control of human biological systems using engineered nanodevices and nanostructures at the molecular level. Nanomedicine uses nano-tools that are 1000 times smaller than a cell for treatment of single cell and is also used in polymer therapeutics, regenerative medicine and targeted drug delivery.

Rise in the awareness related to nanomedicine applications is the vital factor escalating the market growth, also rise in thegovernmentfocus in terms of high funding for life science research and technological advancements in manufacturing process of nanomedicine, increase in the use of nanomedicine as probe or contrast agent in medical imaging techniques to extend the application of imaging and to improve the quality of images and rise in the healthcare expenditures are the major factors among others driving the nanomedicine in central nervous system injury and repair market. Moreover, rise in the technological advancements and modernization in the healthcare devices and rise in the risingresearch and developmentactivities in the healthcare sector will further create new opportunities for nanomedicine in central nervous system injury and repair market in the forecasted period of 2021-2028.

For More Insights Get FREE Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

However, high cost associated with nanomedicine based devices, rise in the stringent government regulations and increase in the risk of environment contamination due to release of toxic nanomaterials are the major factors among others which will obstruct the market growth, and will further challenge the growth of nanomedicine in central nervous system injury and repair market in the forecast period mentioned above.

This nanomedicine in central nervous system injury and repair market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nanomedicine in central nervous system injury and repair market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Nanomedicine in Central Nervous System Injury and Repair Market Scope and Market Size

The nanomedicine in central nervous system injury and repair market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

The nanomedicine in central nervous system injury and repair market is also segmented on the basis ofapplicationinto clinical oncology, infectious diseases, clinical cardiology, orthopedics and others.

Nanomedicine in Central Nervous System Injury and Repair Market Country Level Analysis

The nanomedicine in central nervous system injury and repair market is analysed and market size insights and trends are provided by product and application as referenced above.

The countries covered in the nanomedicine in central nervous system injury and repair market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanomedicine in central nervous system injury and repair market due to rise in the presence of technologically advanced healthcare infrastructure in this region. Asia-Pacific is the expected region in terms of growth in nanomedicine in central nervous system injury and repair market due to rise in the awareness about nanomedicine and high prevalence of chronic diseases in countries in the region.

The country section of the nanomedicine in central nervous system injury and repair market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nanomedicine in central nervous system injury and repair market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for nanomedicine in central nervous system injury and repair market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanomedicine in central nervous system injury and repair market. The data is available for historic period 2010 to 2019.

Read More @ https://www.databridgemarketresearch.com/reports/global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Customization Available: Global Nanomedicine in Central Nervous System Injury and Repair Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @Corporatesales@databridgemarketresearch.com

See original here:

Nanomedicine in Central Nervous System Injury and Repair Market Share, Regional Growth Analysis, Upcoming Trends, Growth Factors and Leading...

Nanorobots Market to close to USD 19576.43 million with CAGR of 12.23% by 2029| Market Size, Growth, Supply, Demand and Analysis – Digital Journal

Nanorobots Marketare also utilised in the maintenance and assembly of complex systems. Nanorobotics widespread use in the medical field is also propelling market revenue growth. In individuals with sickness or weakened immunity, nanorobots can act as antiviral or antibody agents. In addition to cancer detection and treatment, the technique is also being employed in gene therapy.

Get a Sample PDF of the report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanorobots-market

A nano robot is a new technology for designing, programming, and controlling nanoscale robots. Nanorobots are capable of doing specified jobs with components that are on the nanometer size (10-9 meters). Nanorobots are capable of diagnosing certain types of cancer and serve a critical role in human pathogen protection and treatment.Biomedicalinstrumentation, pharmacokinetics, surgical procedures, diabetes monitoring, and other healthcare services can all benefit from nano robots. Data Bridge Market Research analyses that the nanorobots market was valued at USD 7739.19 in 2021 and is further estimated to reach USD 19576.43 million by 2029, and is expected to grow at a CAGR of 12.23% during the forecast period of 2022 to 2029.

Some of the major players operating in the nanorobots market are

To Gain More Insights into the Market Analysis, Browse Summary of the Research [emailprotected] https://www.databridgemarketresearch.com/reports/global-nanorobots-market

NanorobotsMarket Dynamics

Drivers

In the healthcare industry, advances in molecular robot technology are increasingly being used to execute complex tasks and eliminate human error.

Recent research in DNA nanotechnology supports the use of nanorobots inregenerative medicineon a big scale which is further anticipated to contribute to the market growth.

Nanotechnology will be used in the medical field to aid in the detection and treatment of diseases such as diabetes.

Opportunities

In addition, the growing application areas of microscopes and incorporation of microscopy with spectroscopy are further estimated to provide potential opportunities for the growth of the nanorobots market in the coming years.

GlobalNanorobotsMarket Scope and Market Size

The nanorobots market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

On the basis of type, the nanorobots market is segmented into microbivore nano robots, respirocyte Nano robots, clottocyte Nano robots, cellular repair Nanorobots and others. The others segment is further sub segmented into Nano swimmers and bacteria powered robots.

Application

On the basis application, the nanorobots market is segmented into nano medicine, biomedical, mechanical and other applications.

NanorobotsMarket Regional Analysis/Insights

The nanorobots market is analysed and market size insights and trends are provided by country, type and application as referenced above. The countries covered in the nanorobots market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanorobots market due to the rise in the adoption of nano robotics technology. Furthermore, the presence of sophisticated healthcare infrastructure will further boost the growth of the nanorobots market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the nanorobots market due to the rise in the attention of the manufacturers.

Browse the complete table of contents at- https://www.databridgemarketresearch.com/toc/?dbmr=global-nanorobots-market

Related Reports:

Allogenic Stem Cell Therapy Market Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-allogenic-stem-cell-therapy-market

Cancer Stem Cell Therapy Market Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-cancer-stem-cell-therapy-market

North America Stem Cell Therapy Market Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/north-america-stem-cell-therapy-market

Europe Stem Cell Therapy Market Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/europe-stem-cell-therapy-market

Asia-Pacific Stem Cell Therapy Market Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-stem-cell-therapy-market

Middle East and Africa Stem Cell Therapy Market Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/middle-east-and-africa-stem-cell-therapy-market

Asia-Pacific Drug-Device Combination Market Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-drug-device-combination-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:-[emailprotected]

Continue reading here:

Nanorobots Market to close to USD 19576.43 million with CAGR of 12.23% by 2029| Market Size, Growth, Supply, Demand and Analysis - Digital Journal

Notable Thermal and Mechanical Properties of New Hybrid Nanostructures – AZoM

Carbon-based nanomaterials such as carbon nanotubes (CNTs), fullerenes, and graphene receive a great deal of attention today due to their unique physical properties. A new study explores the potential of hybrid nanostructures and introduces a new porous graphene CNT hybrid structure with remarkable thermal and mechanical properties.

Image Credit:Orange Deer studio/Shutterstock.com

The study shows how the remarkable characteristics of novel graphene CNT hybrid structures could be modified by slightly changing the inherent geometric arrangement of CNTs and graphene, plus various filler agents.

The ability to accurately control thermal conductivity and mechanical strength in the graphene CNT hybrid structures make them a potentially suitable candidate for various application areas, especially in advanced aerospace manufacturing where weight and strength are critical.

Carbon nanostructures and hybrids of multiple carbon nanostructures have been examined recently as potential candidates for numerous sensing, photovoltaic, antibacterial, energy storage, fuel cell, and environmental improvement applications.

The most prominent carbon-based nanostructures in the research appear to be CNTs, graphene, and fullerene. These structures exhibit unique thermal, mechanical, electronic, and biological properties due to their extremely small size.

Structures that measure in the sub-nanometer range behave according to the peculiar laws of quantum physics, and so they can be used to exploit nonintuitive phenomena such as quantum tunneling, quantum superposition, and quantum entanglement.

CNTs are tubes made out of carbon and that measure only a few nanometers across in diameter. CNTs display notable electrical conductivity, and some are semiconductor materials.

CNTs also have great tensile strength and thermal conductivity due to their nanostructure, and the strength of covalent bonds formed between carbon atoms.

CNTs are potentially valuable materials for electronics, optics, and composite materials, where they may replace carbon fibers in the next few years. Nanotechnology and materials science also use CNTs in research.

Graphene is a carbon allotrope that is shaped into a single layer of carbon atoms arranged in a two-dimensional lattice structure composed of hexagonal shapes. Graphene was first isolated in a series of groundbreaking experiments byUniversity of Manchester, UK, scientists Andrew Geim and Konstantin Novoselov in 2004, earning them the Nobel Prize for Physics in 2010.

In the few decades since then, graphene has become a useful nanomaterial with exceptionally high tensile strength, transparency, and electrical conductivity leading to numerous and varied applications in electronics, sensing, and other advanced technologies.

A fullerene is another carbon allotrope that has been known for some time. Its molecule consists of carbon atoms that are connected by single and double bonds to form a mesh, which can be closed or partially closed. The mesh is fused with rings of five, six, or seven atoms.

Fullerene molecules can be hollow spheres, ellipsoids, tubes, or a number of other shapes and sizes. Graphene could be considered an extreme member of the fullerene family, although it is considered a member of its own material class.

As well as a great deal of research invested into understanding and characterizing these carbon nanostructures in isolation, scientists are also exploring the properties of hybrid nanostructures that combine two or more nanostructure elements into one material.

For example, foam materials have adjustable properties that make them suitable for practical applications like sandwich structure design, biocompatibility design, and high strength and low weight structure design.

Carbon-based nanofoams have been utilized in medicine as well, examining bone injuries as well as acting as the base for replacement bone tissue.

Carbon-based cellular structures are produced both with chemical vapor deposition (CVD) and solution processing. Spark plasma sintering (SPS) methods are also implemented for using graphene for biological and medical applications.

As a result, scientists have been looking at ways to make three-dimensional carbon foams structurally stable. Research suggests that stable junctions between different types of structures (CNTs, fullerene, and graphene) need to be formed for this material to be stable enough for extensive application.

New research from mechanical engineers at Turkeys Istanbul Technical University introduces a new hybrid nanostructure formed through chemical bonding.

The porous graphene CNT structures were made by organizing graphene around CNTs in nanoribbons. The different geometrical arrangement of graphene nanoribbon layers around CNTs (square, hexagon, and diamond patterns) led to different physical properties being observed in the material, suggesting that this geometric rearrangement could be used to fine-tune the new structure.

The study was published in the journal Physica E: Low-dimensional Systems and Nanostructures in 2022.

Researchers found that the structures with fullerenes inserted, for example, exhibited significant compressive stability and strength without sacrificing tensile strength. The geometric arrangement of carbon nanostructures also had a significant effect on their thermal properties.

Researchers said that these new hybrid nanostructures present important advantages, especially for the aerospace industry. Nanoarchitectures with these hybrid structures may also be utilized in hydrogen storage and nanoelectronics.

Belkin, A., A. Hubler, and A. Bezryadin (2015). Self-Assembled Wiggling Nano-Structures and the Principle of Maximum Entropy Production. Scientific Reports. doi.org/10.1038/srep08323

Degirmenci, U., and M. Kirca (2022). Carbon-based nano lattice hybrid structures: Mechanical and thermal properties. Physica E: Low-dimensional Systems and Nanostructures. doi.org/10.1016/j.physe.2022.115392

Geim, A.K. (2009). Graphene: Status and Prospects. Science. /doi.org/10.1126/science.1158877

Geim, A.K., and K.S. Novoselov (2007). The rise of graphene. Nature Materials. doi.org/10.1038/nmat1849

Monthioux, M., and V.L. Kuznetsov (2006). Who should be given the credit for the discovery of carbon nanotubes? Carbon. doi.org/10.1016/j.carbon.2006.03.019

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

The rest is here:

Notable Thermal and Mechanical Properties of New Hybrid Nanostructures - AZoM

Beyond Animal Testing: How AI is Increasing the Odds in Drug Development – BioSpace

Quris Team Members/Courtesy of Quris AI

Quris AI has developed an alternative to testing on animal models, and each one is smaller than the head of a pin.

Mice are Terrible Predictors

The artificial intelligence (AI) and pharma company has created the Bio-AI Clinical Prediction Platform, which is used to determine which drug candidates will work safely in the human body, and for whom theyll work best.

Currently, drugs are developed and then tested in mice in order to determine their suitability for humans. Mice are terrible predictors, Dr. Isaac Bentwich, Quris founder and CEO, told BioSpace. Out of all the drug candidates today that have in vitro and in vivo testing and then enter into clinical trials, 89% fail. Thats quite dramatic when you stop and think about it.

Biotechnology Innovation Organization (BIO) published a second report on Clinical Development Success Rates and Contributing Factors, analyzing 12,728 clinical and regulatory phase transitions from 9,704 development programs between 2011 and 2020. The analyses found the overall likelihood of approval for developmental candidates to be only 7.9%.

Bentwich offered a creative analogy on the issue, imagining a person who wanted to build a skyscraper and thus contacted the best architect and the best engineer available. They would tell you, you've come to the right place. Were the best in the trade. Here's what we'll do: we will plan 10 skyscrapers for you. We will guarantee that nine of them will crumble. We do not know which. As facetious as this may sound, that's actually the economics of the pharma industry today.

Bentwich is a medical doctor by training and described his unique transition from school into the industry. I was just out of medical school and was dabbling with computerized medical records and decision support systems. It became a hobby. It was either that or pottery, actually. And what began as a year off from continuing with my medical career ended up as a ten-year stint developing a computerized medical record which was very successful. He started three other companies related to AI, computing, biology and medicine before founding Quris.

The Quris Platform

The companys platform uses a combination of three pillars: stem cell technology, AI, and what they call Patients-on-a-Chip. There is a technology used to create miniaturized human organs, a miniaturized liver and a miniaturized brain. Each such miniaturized organ is a third of a millimeter in size, which is the size of the tip of a sewing needle.

Quris' Patients-on-a-Chip technology/courtesy of Quris AI

The mini-organs are created from the cells of an individual person. We then use precision robotics and nanosensors to test thousands of known drugs on these miniaturized patients with interconnected human miniaturized tissues. We use nano sensing to see how these miniaturized patients feel and whether they are personally affected by different drugs.

By testing thousands of drugs on Patients-on-a-Chip, the AI has been trained to determine which are safe, and which are toxic. When a new drug is exposed to the technology, the AI can discern whether its more similar to the toxic drugs or the safe drugs. Bentwich highlighted that importantly, this not only gives a readout of the level of safety, but it shows for whom the drug is safe. We can use this to see that drug X may be good for one individual but not for another.

A unique feature of the mini-organs is their interconnectivity. Bentwich described the first version of the platform, which included the liver, the brain and the blood-brain barrier. This allowed the company to collect data not only on how a drug is processed in the liver but what happens when it crosses the blood-brain barrier.

When we test the drug on our system, we actually let the liver metabolize it. It's a tiny, tiny liver in a tiny well, but it still metabolizes the drug. It breaks it down to different chemicals in the same way that the real liver in the human body does, he described. Only then, it goes through the blood-brain barrier, which mimics exactly how it behaves, allowing only certain molecules to go into the brain. Then, it interacts with the miniaturized brain. The data collected on these interactions between the organs are used to train the AI.

The Bio-AI approach is unique in that its not just sorting through randomized available medical data, but is trained directly in response to known drugs being tested on Patients-on-a-Chip. By utilizing more specific data, the platform generates informed predictions on drug safety and individualized patient suitability.

A Potential Cure for Fragile X Syndrome

The company is developing its first drug for the treatment of Fragile X syndrome, a genetic disorder that causes symptoms related to developmental delays and learning disabilities.

Bentwich said Quris chose to focus on the syndrome because it cannot be mimicked in an animal model, which makes drug development difficult. The company combined its Bio-AI platform with a discovery made by Professor Eyal Benvenisti of The Hebrew University of Jerusalem to begin developing the drug.

The cool thing about the drug that we're developing is that if its successful, it will be the first time that a drug will be attempting to cure the disease. From our initial results, it actually seems to treat the root cause of the disease, not just treat it symptomatically, he said. The drug hopes to address the disruption of fragile-X mental retardation protein(FMRP) production caused by a faulty FMR1 gene in Fragile X syndrome.

Initial studies showed that it seemed to indeed undo the inhibition of this faulty gene, Bentwich shared. If this is successful, we may be onto something that will impact the lives of many patients. He said clinical testing will begin within the next 12 months.

Redefining Nonclinical Testing

Earlier this month, the United States House of Representatives passed a bill to amend the Federal Food, Drug, and Cosmetic Act. Alternatives to animal testing are now allowed in assessing the efficacy of a drug. Such nonclinical tests can include computer modeling, cell-based assays, organ chips and other biology-based test methods.

Bentwich said that a revolution is happening, and Quris is at the center of it. We believe that using novel combinations of Patients-on-a-Chip together with powerful AI, we can replace outdated and ineffective mice experiments, or at least reduce them.

He pointed out that technology can be used as a tool to speed the drug development timeline. A vaccine which usually takes 10 to 15 years to develop was developed within a year using cutting edge technologies like Modernas with its COVID vaccine, and like Quris is now using in drug development.

Bentwich sees a future of drugs that are fitted to individuals rather than to the masses. We shrink the time that it takes to develop a drug. Were hoping that it sparks a revolution in drug development, by developing drugs much faster, much cheaper and that are more personalized.

Continue reading here:

Beyond Animal Testing: How AI is Increasing the Odds in Drug Development - BioSpace